Arena Pharmaceuticals Downgraded By: MarketMinute.com Stock News March 16, 2009 at 17:49 PM EDT Canaccord Adams downgraded Arena Pharmaceuticals Inc. (Nasdaq: ARNA) sending the stock price plummeting $1.10 to close at $3.99.